<p>Wells Dermatology Clinic's Apgujeong main branch is conducting a clinical trial for acne treatment through human microbiome research — the first of its kind in the aesthetic dermatology field. The microbiome refers to the collective genetic information of intestinal microorganisms that coexist with humans. This study is specifically limited to analyzing the genomic information of the skin flora (all microorganisms including viruses, bacteria, and fungi) that reside on the skin.</p>
<p>Wells Dermatology announced on the 7th that leading research institutions in the United States and Luxembourg, Genome & Company led by CEO Bae Ji-su, and the Apgujeong main branch of Wells Dermatology under Director Choi Won-woo are jointly conducting a clinical research study on acne treatment.</p>
<p>This study aims to reinterpret the types of causative bacteria known to be responsible for the pathogenesis of acne, and to identify differences in skin flora at the genomic analysis level by comparing acne patients with healthy individuals who do not have acne. The goal is to propose a new treatment strategy for acne based on these findings. In addition, Wells Dermatology plans to expand the scope of this research in the future to include conditions such as atopic dermatitis and allergic dermatitis.</p>
<p>Human flora genomic research involves interpreting the genomic information of microorganisms that coexist within the body in order to distinguish between healthy flora and disease-associated flora, or between flora involved in immune enhancement and flora involved in immune suppression — with the aim of applying this knowledge to the treatment of cancer and intractable diseases.</p>
<p>Until now, treatment has been centered on indiscriminate drug therapies with side effects, such as antibiotics and non-steroidal anti-inflammatory drugs. Flora genomic research is expected to enable natural healing and biological therapies that selectively eliminate only harmful bacteria or transplant and culture only beneficial bacteria.</p>
<p>Wells Dermatology is recruiting participants for this clinical study. Eligible subjects are acne patients who have not received any acne-related treatments — including medication or laser therapy — in the past three months. Participants will receive one complimentary acne scaling session.</p>
<br>
<p>
<img src="https://www.sportschosun.com/article/html/2016/08/07/2016080801000697900050241.jpg" alt="" style="max-width:100%">
</p></p>
<p><a href="https://sports.chosun.com/news/ntype.htm?id=201608080100069790005024&amp;servicedate=20160807" target="_blank" rel="noopener">View original article →</a></p>